← Browse by Condition
Medical Condition

dyspepsia

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for dyspepsia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — dyspepsia Clinical Trials

How many clinical trials are currently recruiting for dyspepsia?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for dyspepsia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for dyspepsia?
dyspepsia research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a dyspepsia clinical trial?
Eligibility criteria for dyspepsia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Yongquan Shi 1 trial
Harokopio University 1 trial
Knappschaft Kliniken GmbH 1 trial

Recruiting Clinical Trials

NCT07139366 Phase 4
Recruiting
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
Enrollment
1,248 pts
Location
China
Sponsor
Yongquan Shi
View Trial →
NCT06909890
Recruiting
A Study of Chios Mastic Water in Dyspepsia
Enrollment
60 pts
Location
Greece
Sponsor
Harokopio University
View Trial →
NCT07510984
Recruiting
Symptoms and Quality of Life in Patients With Heterotopic Gastric Mucosa (HGM)
Enrollment
721 pts
Location
Germany
Sponsor
Knappschaft Kliniken GmbH
View Trial →

Related Conditions

gastritis (1) helicobacter pylori infection (1) gastric cancer (1) peptic ulcer (1) heterotopic gastric mucosa of the proximal esophagus (1) gastric inlet patches (1) dysphagia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology